Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

NCT03542006 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

Central Serous Chorioretinopathy

Interventions

DRUG: Brinzolamide Ophthalmic

Sponsor

Tel-Aviv Sourasky Medical Center